An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy
Cancer Letters · 2025-03 · 612 · 217485
DOI: 10.1016/j.canlet.2025.217485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-03. Verfasst von Guangzhao Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China; Harway Pharma Co., Ltd, Weifang, 262700, China. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Mitochondria, Apoptosis, Immunotherapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Though immunogenic cell death (ICD) has garnered significant attention in the realm of anticancer therapies, effectively stimulating strong immune responses with adequate antigen presentation in deep-seated cancers remains challenging. Herein, to promote antigen presentation, an efficient dual-targeted photodynamic ICD inducer is developed. Due to the enhanced spin-orbit coupling and electron structure modulation, the Cy5-I-CF3 probe showcases exceptional reactive oxygen species (ROS) generation capacity within cancer cells. The Cy5-I-CF3 also displays the co-targeting ability toward the endoplasmic reticulum (ER) and mitochondria. More importantly, the in-situ ROS generation synergistically facilitates the interaction between ER and mitochondria, thereby invoking a more robust ER stress response through cascade amplification mechanisms, resulting in substantial release of damage-associated molecular patterns (DAMPs) and strong induction of ICD. This augmentation ultimately enhances the endogenous antigen presentation machinery. Adequate antigen presentation promotes the dendritic cell (DC) maturation and infiltration of cytotoxic T lymphocytes (CTLs) to realize efficient immunotherapy. As a result, Cy5-I-CF3 notably restrains the growth of distant and primary cancers by photodynamic-induced immunotherapy. Our research offers valuable insights for the design of efficacious ICD inducers, advancing the utilization of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China; Harway Pharma Co., Ltd, Weifang, 262700, China.
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China. Electronic address: lifh@sdsmu.edu.cn.
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States. Electronic address: chenz@stjohns.edu.
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China. Electronic address: weily@sdsmu.edu.cn.
Förderung
- Shandong Province Natural Science Foundation
Zitieren
APA
Xu, G., Chen, S., Yang, H., Feng, X., Li, F., Zhao, H., Sun, L., Yan, P., Chen, Y., Guo, G., Sun, W., Song, W., Chen, Z. S., Wei, L., & Zhong, W. (2025). An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy. Cancer Letters, 612, 217485. https://doi.org/10.1016/j.canlet.2025.217485
Vancouver
Xu G, Chen S, Yang H, Feng X, Li F, Zhao H, et al. An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy. Cancer Letters. 2025;612:217485. doi:10.1016/j.canlet.2025.217485
BibTeX
@article{Xu2025,
author = {Xu, Guangzhao and Chen, Shuzhen and Yang, Hekai and Feng, Xiaozhe and Li, Fahui and Zhao, Huishuang and Sun, Le and Yan, Ping and Chen, Yuxi and Guo, Guanhong and Sun, Wen and Song, Weiguo and Chen, Zhe-Sheng and Wei, Liuya and Zhong, Wenda},
title = {An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy},
journal = {Cancer Letters},
year = {2025},
volume = {612},
pages = {217485},
doi = {10.1016/j.canlet.2025.217485}
}
EUVIMED